Clinical Trial Update: GnRH Agonist (GnRHa) Withdrawal at Late Stage of Long Protocol and the Incidence of Ovarian Hyper-stimulation [NA]

View source ↗

Summary

Clinical trial update from Nanjing University examining withdrawal of a GnRH agonist at late stage of the long protocol and its effect on ovarian hyper-stimulat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility
• Polycystic Ovary Syndrome

Drugs mentioned

• Gonadotropin-releasing-hormone agonist (GnRH agonist) (GnRH agonist)

Snippet

Sponsor: Nanjing University | Conditions: Infertile High-risk Patients With Polycystic Ovaries | NA | Status: UNKNOWN